141 related articles for article (PubMed ID: 16325708)
1. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
2. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
3. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity.
Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF
Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481
[TBL] [Abstract][Full Text] [Related]
4. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
5. Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost.
Sakurai M; Higashide T; Takahashi M; Sugiyama K
Ophthalmology; 2007 Jun; 114(6):1039-45. PubMed ID: 17467803
[TBL] [Abstract][Full Text] [Related]
6. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
[TBL] [Abstract][Full Text] [Related]
7. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
8. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.
Defoor J; Martens K; Zielinska D; Matthijs G; Van Nerum H; Schepers D; Fagard R; Vanhees L
Eur Heart J; 2006 Apr; 27(7):808-16. PubMed ID: 16421173
[TBL] [Abstract][Full Text] [Related]
9. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
10. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
[TBL] [Abstract][Full Text] [Related]
11. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
12. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
13. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
Pharmacogenomics J; 2006; 6(3):174-8. PubMed ID: 16402084
[TBL] [Abstract][Full Text] [Related]
14. Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.
Tafel J; Branscheid I; Skwarna B; Schlimme M; Morcos M; Algenstaedt P; Hinney A; Hebebrand J; Nawroth P; Hamann A
Diabetes Obes Metab; 2004 Nov; 6(6):452-5. PubMed ID: 15479221
[TBL] [Abstract][Full Text] [Related]
15. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
16. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
[TBL] [Abstract][Full Text] [Related]
17. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
19. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
20. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
